Stock HBMNE HBM HEALTHCARE INVESTMENTS AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings HBM Healthcare Investments AG Swiss Exchange

Equities

HBMNE

CH0257717097

Delayed Swiss Exchange
Other stock markets
 06:35:07 28/06/2024 pm IST 		5-day change 1st Jan Change
207 CHF +0.24% Intraday chart for HBM Healthcare Investments AG -1.66% +13.86%
28/05 HBM Healthcare Flags NAV Boost from Yellow Jersey-Johnson & Johnson Deal MT
23/05 HBM Healthcare Investments' Portfolio Company to Buy Laboratorios Biopas Group MT

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

Weaknesses

  • Based on current prices, the company has particularly high valuation levels.

Ratings chart - Surperformance

Sector: Investment Management & Fund Operators

1st Jan change Capi. Investor Rating ESG Refinitiv
HBM HEALTHCARE INVESTMENTS AG Stock HBM Healthcare Investments AG
+13.86% 1.56B -
HERCULES CAPITAL, INC. Stock Hercules Capital, Inc.
+21.66% 3.24B
B-
UMBRA COMPANIES INC. Stock Umbra Companies Inc.
+12.50% 1.76B - -
OCTOPUS TITAN VCT PLC Stock Octopus Titan VCT plc
-11.54% 1.22B - -
MOLTEN VENTURES PLC Stock Molten Ventures Plc
+33.47% 902M
B+
CION INVESTMENT CORPORATION Stock CION Investment Corporation
+7.52% 651M -
VERUSA HOLDING Stock Verusa Holding
+56.73% 651M -
D+
OCTOPUS APOLLO VCT PLC Stock Octopus Apollo VCT plc
-4.17% 503M - -
WOORI TECHNOLOGY INVESTMENT CO., LTD Stock Woori Technology Investment Co., Ltd
+19.88% 434M - -
GOZDE GIRISIM SERMAYESI YATIRIM ORTAKLIGI Stock Gozde Girisim Sermayesi Yatirim Ortakligi
+34.39% 320M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. HBMN Stock
  4. HBMNE Stock
  5. Ratings HBM Healthcare Investments AG